Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 13/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.38 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.38 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL999113 | 0.97 | KCNH2 (0.77) | KCNH2CYP3A4CSNK1DCSNK1EP2RX7 | |
| SCHEMBL12952111 | 0.93 | KCNH2 (0.67) | KCNH2CYP3A4CSNK1DCSNK1EP2RX7 | |
| SCHEMBL12952256 | 0.91 | KCNH2 (0.66) | KCNH2CYP3A4CSNK1DCSNK1ECNR2 | |
| SCHEMBL20121556 | 0.90 | KCNH2 (0.66) | KCNH2CYP3A4CSNK1DCSNK1EP2RX7 | |
| SCHEMBL12952192 | 0.89 | KCNH2 (0.69) | KCNH2CYP3A4CSNK1DCSNK1EP2RX7 | |
| SCHEMBL20121612 | 0.89 | KCNH2 (0.80) | KCNH2CYP3A4P2RX7 | |
| SCHEMBL12951891 | 0.88 | KCNH2 (0.81) | KCNH2CYP3A4CSNK1DCSNK1EP2RX7 | |
| SCHEMBL12952278 | 0.87 | KCNH2 (0.68) | KCNH2CYP3A4CSNK1DCSNK1E | |
| SCHEMBL12952038 | 0.87 | KCNH2 (0.73) | KCNH2CYP3A4CSNK1DCSNK1ECNR2 | |
| SCHEMBL20121548 | 0.87 | KCNH2 (0.80) | KCNH2CYP3A4P2RX7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963454-B2 | Compounds and compositions for the treatment of parasitic disease | NOVARTIS AG (CH) | 2018-05-08 | — | — | US | disclosed |